Immunoscore: A test to improve the care and treatment of colon cancer

(INSERM (Institut national de la sant é et de la recherche m é dicale)) With Immunoscore, a test devised by a team of researchers from Inserm and Universit é Paris Descartes and doctors from the Paris AP-HP hospitals, disease progression in patients with colon cancer can now be defined more accurately. According to an international study conducted in more than 2,500 patients, Immunoscore has proved effective in predicting which patients are at high risk of tumor recurrence and, as such, would benefit from intensified treatment following surgery. These results have been published in The Lancet.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news